Connective tissue growth factor (CTGF) from basics to clinics
Publication date
2018-08-01
Authors
Ramazani, Yasaman
Knops, Noël
Elmonem, Mohamed A.
Nguyen, Tri Q.
Arcolino, Fanny Oliveira
van den Heuvel, Lambert
Levtchenko, Elena
Kuypers, Dirk
Goldschmeding, Roel
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Connective tissue growth factor, also known as CCN2, is a cysteine-rich matricellular protein involved in the control of biological processes, such as cell proliferation, differentiation, adhesion and angiogenesis, as well as multiple pathologies, such as tumor development and tissue fibrosis. Here, we describe the molecular and biological characteristics of CTGF, its regulation and various functions in the spectrum of development and regeneration to fibrosis. We further outline the preclinical and clinical studies concerning compounds targeting CTGF in various pathologies with the focus on heart, lung, liver, kidney and solid organ transplantation. Finally, we address the advances and pitfalls of translational fibrosis research and provide suggestions to move towards a better management of fibrosis.
Keywords
CCN2, Connective tissue growth factor, Fibrosis, Marker and therapeutic target, Matricellular protein, Taverne, Molecular Biology
Citation
Ramazani, Y, Knops, N, Elmonem, M A, Nguyen, T Q, Arcolino, F O, van den Heuvel, L, Levtchenko, E, Kuypers, D & Goldschmeding, R 2018, 'Connective tissue growth factor (CTGF) from basics to clinics', Matrix Biology, vol. 68-69, pp. 44-66. https://doi.org/10.1016/j.matbio.2018.03.007